Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Antigens, Neoplasm/genetics"'
Autor:
Brian Stevenson, Marion Arnaud, Michal Bassani-Sternberg, Vincent Zoete, Florian Huber, Blanca Navarro Rodrigo, Marta A S Perez, Raphael Genolet, Petra Baumgaertner, Chloe Chong, Julien Schmidt, Lana E. Kandalaft, Philippe Guillaume, Sara Bobisse, Alexandre Harari, Johanna Chiffelle, Morgane Magnin, Melita Irving, Daniel E. Speiser, George Coukos, David Gfeller, Tu Nguyen-Ngoc
Publikováno v:
Nature biotechnology, vol. 40, no. 5, pp. 656-660
The identification of patient-specific tumor antigens is complicated by the low frequency of T cells specific for each tumor antigen. Here we describe NeoScreen, a method that enables the sensitive identification of rare tumor (neo)antigens and of co
Autor:
Tom Lund, Roberto Salgado, Rachel Rosenthal, Shan E Ahmed Raza, Marco Sereno, Sergio A. Quezada, Claire Rachel Smith, Selvaraju Veeriah, Leah Officer, Mariam Jamal-Hanjani, Nicholas McGranahan, David Moore, Yinyin Yuan, Maise Al Bakir, Allan Hackshaw, Crispin T. Hiley, Sherene Loi, Luis Zapata, John Le Quesne, Charles Swanton, Teresa Marafioti, Ayse Akarca, Khalid AbdulJabbar
Publikováno v:
Nature Medicine
TRACERx Consortium & Blackhall, F 2020, ' Geospatial immune variability illuminates differential evolution of lung adenocarcinoma ', Nature Medicine, vol. 26, no. 7, pp. 1054-1062 . https://doi.org/10.1038/s41591-020-0900-x
Nat Med
TRACERx Consortium & Blackhall, F 2020, ' Geospatial immune variability illuminates differential evolution of lung adenocarcinoma ', Nature Medicine, vol. 26, no. 7, pp. 1054-1062 . https://doi.org/10.1038/s41591-020-0900-x
Nat Med
Remarkable progress in molecular analyses has improved our understanding of the evolution of cancer cells towards immune escape(1–5). However, the spatial configurations of immune and stromal cells, which may shed light on the evolution of immune e
Autor:
Moncef Benkhalifa, Stéphane Viville, Sabine Kliesch, Nicolas Charlet-Berguerand, Munevver Serdarogullari, Angeline Gaucherot, Isabelle Aknin, Ozlem Okutman, Frank Tüttelmann, Viviana Herbepin, Mustafa Bahceci, Meral Gultomruk, Ellen Goossens, Jean Marie Garnier, Valérie Lamour, Yoni Baert, Jean Muller, Emre Bakircioglu, Valerie Skory, Marius Teletin, Albrecht Röpke
Publikováno v:
Journal of Assisted Reproduction and Genetics
Journal of Assisted Reproduction and Genetics, Springer Verlag, 2017, 34 (5), pp.683-694. ⟨10.1007/s10815-017-0900-z⟩
Journal of Assisted Reproduction and Genetics, 2017, 34 (5), pp.683-694. ⟨10.1007/s10815-017-0900-z⟩
Journal of Assisted Reproduction and Genetics, Springer Verlag, 2017, 34 (5), pp.683-694. ⟨10.1007/s10815-017-0900-z⟩
Journal of Assisted Reproduction and Genetics, 2017, 34 (5), pp.683-694. ⟨10.1007/s10815-017-0900-z⟩
PURPOSE: The purpose of this study was to identify mutations that cause non-syndromic male infertility using whole exome sequencing of family cases. METHODS: We recruited a consanguineous Turkish family comprising nine siblings with male triplets; tw
Autor:
Imad Ghazi, Isabelle Perrault, Nicolas Goudin, Jean-Michel Rozet, Josseline Kaplan, Sabine Defoort-Dhellemmes, Iris Barny, Christel Michel, Xavier Gérard
Publikováno v:
Genes, Vol 10, Iss 5, p 368 (2019)
Genes, vol. 10, no. 5
Genes, vol. 10, no. 5
Mutations in CEP290 encoding a centrosomal protein important to cilia formation cause a spectrum of diseases, from isolated retinal dystrophies to multivisceral and sometimes embryo–lethal ciliopathies. In recent years, endogenous and/or selective
Autor:
Pedro M. S. Alves, Nermin Halkic, Hanifa Bouzourene, Maha Ayyoub, Jean-Claude Givel, Daniel E. Speiser, Gabriel Bricard, Frédéric Lévy, Henri Vuilleumier, Sebastien Viatte, Nicole Lévy, Pedro Romero
Publikováno v:
Cancer immunology, immunotherapy, vol. 56, no. 6, pp. 839-847
Tumor-specific gene products, such as cancer/testis (CT) antigens, constitute promising targets for the development of T cell vaccines. Whereas CT antigens are frequently expressed in melanoma, their expression in colorectal cancers (CRC) remains poo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3da317149a01c325b8fa35d43b6d4f09
http://doc.rero.ch/record/318666/files/262_2006_Article_228.pdf
http://doc.rero.ch/record/318666/files/262_2006_Article_228.pdf
Autor:
Christina Dahl, Christer Lundell-Ek, Henrik J. Ditzel, Jann Mortensen, Karine N. Dzhandzhugazyan, Line Bille Madsen, Johnny Jon Fang, Helle Broholm, Walter Fischer, Morten F. Gjerstorff, Tim Lundby, Ian Law, Per Guldberg, Rikke Sick Andersen, Martin Roland Jensen, Alexei F. Kirkin, Aase Wagner
Publikováno v:
Kirkin, A F, Dzhandzhugazyan, K N, Guldberg, P, Fang, J J, Andersen, R S, Dahl, C, Mortensen, J, Lundby, T, Wagner, A, Law, I, Broholm, H, Madsen, L, Lundell-Ek, C, Gjerstorff, M F, Ditzel, H J, Jensen, M R & Fischer, W 2018, ' Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells ', Nature Communications, vol. 9, 785 . https://doi.org/10.1038/s41467-018-03217-9
Nature Communications, Vol 9, Iss 1, Pp 1-12 (2018)
Nature Communications
Kirkin, A F, Dzhandzhugazyan, K N, Guldberg, P, Fang, J J, Andersen, R S, Dahl, C, Mortensen, J, Lundby, T, Wagner, A, Law, I, Broholm, H, Madsen, L, Lundell-Ek, C, Gjerstorff, M F, Ditzel, H J, Jensen, M R & Fischer, W 2018, ' Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells ', Nature Communications, vol. 9, no. 1, 785 . https://doi.org/10.1038/s41467-018-03217-9
Nature Communications, Vol 9, Iss 1, Pp 1-12 (2018)
Nature Communications
Kirkin, A F, Dzhandzhugazyan, K N, Guldberg, P, Fang, J J, Andersen, R S, Dahl, C, Mortensen, J, Lundby, T, Wagner, A, Law, I, Broholm, H, Madsen, L, Lundell-Ek, C, Gjerstorff, M F, Ditzel, H J, Jensen, M R & Fischer, W 2018, ' Adoptive cancer immunotherapy using DNA-demethylated T helper cells as antigen-presenting cells ', Nature Communications, vol. 9, no. 1, 785 . https://doi.org/10.1038/s41467-018-03217-9
In cancer cells, cancer/testis (CT) antigens become epigenetically derepressed through DNA demethylation and constitute attractive targets for cancer immunotherapy. Here we report that activated CD4+ T helper cells treated with a DNA-demethylating ag
Autor:
Nine V A M Knoers, René J. M. Bindels
Publikováno v:
The New England Journal of Medicine, 374, 19, pp. 1888-90
New England Journal of Medicine, 374(19), 1888-1890. MASSACHUSETTS MEDICAL SOC
The New England Journal of Medicine, 374, 1888-90
New England Journal of Medicine, 374(19), 1888-1890. MASSACHUSETTS MEDICAL SOC
The New England Journal of Medicine, 374, 1888-90
Bartter’s syndrome is a rare, genetically heterogeneous disorder characterized by renal salt wasting, hypokalemic metabolic alkalosis, and secondary hyperaldosteronism with normal to low blood pressure. Two distinct presentations of the syndrome ex
Autor:
Biserka Radošević-Stašić, Tanja Grubić-Kezele, Hrvoje Jakovac, Čedomila Milin, Gordana Blagojević Zagorac, Robert Domitrović
Publikováno v:
Clinical and Developmental Immunology
Volume 213
es http://dx.doi.org/10.1155/2013/750406
Clinical & developmental immunology
Volume 2013
Clinical and Developmental Immunology, Vol 2013 (2013)
Volume 213
es http://dx.doi.org/10.1155/2013/750406
Clinical & developmental immunology
Volume 2013
Clinical and Developmental Immunology, Vol 2013 (2013)
In a search of peripheral factors that could be responsible for the discrepancy in susceptibility to EAE in Albino Oxford (AO) and Dark Agouti (DA) rats, we estimated the expression of metallothioneins I/II (MT), heat shock protein-gp96, interleukin
Autor:
George M. Spyrou, Johannes T. Roehr, Vasiliki Nicolaou, Elizabeth Kodela, Andreas Katsambas, Evangelos Evangelou, Foteini Chatzinasiou, Katerina P. Kypreou, Christina M. Lill, John P. A. Ioannidis, I. Stefanaki, Hensin Tsao, Lars Bertram, Alexander J. Stratigos
Publikováno v:
JNCI Journal of the National Cancer Institute. 103:1227-1235
BACKGROUND: Although genetic studies have reported a number of loci associated with cutaneous melanoma (CM) risk, a comprehensive synopsis of genetic association studies published in the field and systematic meta-analysis for all eligible polymorphis
Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study
Autor:
Tsun Leung Chan, Eugène T P Verwiel, Irma Kluijt, Diana Eccles, Rolf H. Sijmons, Egbert J.W. Redeker, Rachel S. van der Post, Encarna B. Gomez Garcia, Reinhard Büttner, Cora M. Aalfs, Roland P. Kuiper, Johan J.P. Gille, Bernadette P M van Nesselrooij, Frans B. L. Hogervorst, Marjolijn J L Ligtenberg, Tracy Graham, Julie O. Culver, Edith Olah, Monique Goossens, Carli M. J. Tops, Elke Holinski-Feder, David J. Bunyan, Marielle E. van Gijn, Frederik J. Hes, Suet Yi Leung, Pierre O. Chappuis, Monika Morak, Edward M Leter, Nils Rahner, Lea Velsher, János Papp, Renee C. Niessen, J. Han van Krieken, Lambertus A. Kiemeney, Ad Geurts van Kessel, Charlotte W. Ockeloen, Nicoline Hoogerbrugge, Marlies Kempers, Iris D. Nagtegaal, Verena Steinke, Hans K. Schackert, Matthias Kloor, Melanie R. Palomares, Sapna Syngal, Pierre Hutter, Elena M. Stoffel
Publikováno v:
Kempers, M J E, Kuiper, R P, Ockeloen, C W, Chappuis, P O, Hutter, P, Rahner, N, Schackert, H K, Steinke, V, Holinski-Feder, E, Morak, M, Kloor, M, Buttner, R, Verwiel, E T P, van Krieken, J H, Nagtegaal, I D, Goossens, M, van der Post, R S, Niessen, R C, Sijmons, RH, Kluijt, I, Hogervorst, F B L, Leter, E M, Gille, J J P, Aalfs, C M, Redeker, E J W, Hes, F J, Tops, C M J, van Nesselrooij, B P M, van Gijn, M E, Garcia, E B G, Eccles, D M, Bunyan, D J, Syngal, S, Stoffel, E M, Culver, J O, Palomares, M R, Graham, T, Velsher, L, Papp, J, Olah, E, Chan, T L, Leung, S Y, van Kessel, A G, Kiemeney, L A L M, Hoogerbrugge, N & Ligtenberg, M J L 2011, ' Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: a cohort study ', Lancet Oncology, vol. 12, no. 1, pp. 49-55 . https://doi.org/10.1016/S1470-2045(10)70265-5
The Lancet Oncology, 49-55
STARTPAGE=49;ENDPAGE=55;TITLE=The Lancet Oncology
Lancet Oncology, 12, 1, pp. 49-55
Lancet oncology, 12(1), 49-55. Elsevier Science
Lancet Oncology, 12, 49-55
lancet oncology, 12(1), 49-55. Lancet Publishing Group
Lancet Oncology, 12(1), 49-55. ELSEVIER SCIENCE INC
Lancet Oncology, 12(1), 49-55. Lancet Publishing Group
The Lancet Oncology, 49-55
STARTPAGE=49;ENDPAGE=55;TITLE=The Lancet Oncology
Lancet Oncology, 12, 1, pp. 49-55
Lancet oncology, 12(1), 49-55. Elsevier Science
Lancet Oncology, 12, 49-55
lancet oncology, 12(1), 49-55. Lancet Publishing Group
Lancet Oncology, 12(1), 49-55. ELSEVIER SCIENCE INC
Lancet Oncology, 12(1), 49-55. Lancet Publishing Group
Summary Background Lynch syndrome is caused by germline mutations in MSH2, MLH1, MSH6 , and PMS2 mismatch-repair genes and leads to a high risk of colorectal and endometrial cancer. We previously showed that constitutional 3′ end deletions of EPCAM